AKYA,Akoya Biosciences, Inc. | Healthcare

Healthcare

AKYA

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Akoya Biosciences, Inc.AKYA

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa.

The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow.

It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI.

The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Latest News >

Applovin Insider Sold Shares Worth $809,268, According to a Recent SEC Filing

Mar 12, 2024

04:26 PM EDT, 03/12/2024 (MT Newswires) -- Katie Kihorany Jansen, Chief Marketing Officer, on March 08, 2024, sold 12,650 shares in Applovin ( APP ) for $809,268. Following the Form 4 filing with the SEC, Jansen has control over a total of 1,418,354 shares of the company, with 1,264,284 shares held directly and 154,070 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218024002597/xslF345X03/primarydocument.xml Price:...

Applovin Insider Sold Shares Worth $1,625,000, According to a Recent SEC Filing

Mar 12, 2024

04:26 PM EDT, 03/12/2024 (MT Newswires) -- Victoria Valenzuela, Chief Legal Officer and Corporate Secretary, on March 08, 2024, sold 25,000 shares in Applovin ( APP ) for $1,625,000. Following the Form 4 filing with the SEC, Valenzuela has control over a total of 521,560 shares of the company, with 521,560 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218024002596/xslF345X03/primarydocument.xml Price: 61.85, Change:...

Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing

Mar 12, 2024

04:27 PM EDT, 03/12/2024 (MT Newswires) -- Trent G Kamke, Senior Vice President, Operations, on March 08, 2024, sold 4,542 shares in Lemaitre Vascular ( LMAT ) for $309,684. Following the Form 4 filing with the SEC, Kamke has control over a total of 4,561 shares of the company, with 4,561 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1158895/000143774924007457/xslF345X03/rdgdoc.xml ...

Coinbase Global Insider Sold Shares Worth $5,458,750, According to a Recent SEC Filing

Mar 12, 2024

04:30 PM EDT, 03/12/2024 (MT Newswires) -- Lawrence J Brock, Chief People Officer, on March 08, 2024, sold 21,835 shares in Coinbase Global ( COIN ) for $5,458,750. Following the Form 4 filing with the SEC, Brock has control over a total of 13,556 shares of the company, with 13,556 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1679788/000167978824000039/xslF345X03/wk-form4_1710275332.xml Price: 247.57, Change: -8.57,...